FerlayJ, 2015.Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012,Int J Cancer 136 E359 -86
LlovetJM,RealMI,MontañaX, 2002.Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: A randomised controlled trial,Lancet 359 1734 -9
LvF,LuD,HeYS,XiaoJK,ZhouCZ,ChengDL, 2016.Liver abscess formation following transarterial chemoembolization: Clinical features, risk factors, bacteria spectrum, and percutaneous catheter drainage,Medicine 95 e3503 -
TaslakianB,SridharD, 2017.Post-procedural care in interventional radiology: What every interventional radiologist should knowPart I: Standard post-procedural instructions and follow-up care,Cardiovasc Intervent Radiol 40 481 -95
LiYJ,LiGW,HuangXF,ZengQA., 2016.Clinical significance of antibiotic prophylaxis in transarterial therapy of hepatocellular carcinoma: A meta- analysis,Chin Arch Gen Surg (Electronic Edition) 10 231 -4
PlentzRR,LankischTO,BastürkM., 2005.Prospective analysis of German patients with hepatocellular carcinoma undergoing transcatheter arterial chemoembolization with or without prophylactic antibiotic therapy,J Gastroenterol Hepatol 20 1134 -6
GaoF,ZhangXN,ChenMZ,QianT,MaAY,YinHB, 2013.Prophylactic use of antibiotics after interventional procedures for primary hepatocellular carcinoma: Its clinical significance,J Intervent Radiol 22 151 -3
ZhuWY,LiuJY,ZhouYH,LiuL,FengS,GaoB, 2014.Discussion of prophylactic use of antibiotics in interventional procedures for primary hepatocellular carcinoma,Shandong Medi J 54 59 -61
ShaoJY,ChangCL,WuSY, 2015.Statin-based palliative therapy for hepatocellular carcinoma,Medicine (Baltimore) 94 e1801 -
LiF,GuoZ,WangH, 2013.Influencing elements and treatment strategies associated with the relapse of hepatocellular carcinoma after surgery,Hepatogastroenterology 60 1148 -55
LiKW,LiX,WenTF,LuWS, 2013.The effect of postoperative TACE on prognosis of HCC: An update,Hepatogastroenterology 60 248 -51
ReedRA,TeitelbaumGP,DanielsJR, 1994.Prevalence of infection following hepatic chemoembolization with cross-linked collagen with administration of prophylactic antibiotics,J Vasc Interv Radiol 5 367 -71
DarraghFH,WilliamCT, 2011.The infectious complications of interventional radiology based procedures in gastroenterology and hepatology,J Gastrointestin Liver Dis 20 71 -5
XiaJL,RenZG,YeSL, 2006.Study of severe and rare complications of transarterial chemoembolization (TACE) for liver cancer,Eur J Radiol 59 407 -12
TarazovPG,PolysalovVN,ProzorovskijKV,GrishchenkovaIV,RozengauzEV, 2000.Ischemic complications of transcatheter arterial chemoembolization in liver malignancies,Acta Radiol 41 156 -60
HuangSF,KoCW,ChangCS,ChenGH, 2003.Liver abscess formation after transarterial chemoembolization for malignant hepatic tumor,Hepatogastroenterology 50 1115 -8
de BaereT,RocheA,AmenabarJM,LagrangeC,DucreuxM,RougierP, 1996.Liver abscess formation after local treatment of liver tumors,Hepatology 23 1436 -40
EbisutaniC,SatoS,NishiK,InoueH,YoshieT,KinoshitaY., 2010.Antibiotic prophylaxis in transcatheter treatment of hepatocellular carcinoma: An open randomized prospective study of oral versus intravenous administration,Intern Med 49 1059 -65
ZhengPF,ZhangJS, 2007.The meta analysis of recent complications after the interventional therapy in the advanced hepatocellular carcinoma patients,Shanghai J Prevent Med 19 517 -9
FiorentiniG,AlibertiC,TilliM,MulazzaniL,GrazianoF,PaoloG, 2012.Intra-arterial infusion of irinotecan-loaded drug-elutin beads (DEBIRI) versus intravenous therapy (FOLFIRI) for hepatic metastases from colorectal cancer: Final results of a phase study,Anticancer Res 32 1387 -95